5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol

C161H169Br7N27O16+ — CID 172918593

IUPAC5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
SMILESCCC(CC)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCC(O)CN(C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCC(O)C[NH+](C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCCN1CCN(CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CCN(CC)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.Oc1[nH]c2ccc(Br)cc2c1C1=Nc2ccccc2/C1=N\OCCC1CCCC1.Oc1[nH]c2ccc(Br)cc2c1C1=Nc2ccccc2/C1=N\OCCN1CCCC1
InChIInChI=1S/C25H28BrN5O2.2C23H25BrN4O3.C23H22BrN3O2.C23H24BrN3O2.C22H21BrN4O2.C22H23BrN4O2/c1-2-9-30-10-12-31(13-11-30)14-15-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-16-17(26)7-8-21(19)28-25(22)32;2*1-3-15(29)13-28(2)10-11-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-12-14(24)8-9-19(17)26-23(20)30;24-15-9-10-19-17(13-15)20(23(28)26-19)22-21(16-7-3-4-8-18(16)25-22)27-29-12-11-14-5-1-2-6-14;1-3-14(4-2)11-12-29-27-21-16-7-5-6-8-18(16)25-22(21)20-17-13-15(24)9-10-19(17)26-23(20)28;23-14-7-8-18-16(13-14)19(22(28)25-18)21-20(15-5-1-2-6-17(15)24-21)26-29-12-11-27-9-3-4-10-27;1-3-27(4-2)11-12-29-26-20-15-7-5-6-8-17(15)24-21(20)19-16-13-14(23)9-10-18(16)25-22(19)28/h3-8,16,28,32H,2,9-15H2,1H3;2*4-9,12,15,26,29-30H,3,10-11,13H2,1-2H3;3-4,7-10,13-14,26,28H,1-2,5-6,11-12H2;5-10,13-14,26,28H,3-4,11-12H2,1-2H3;1-2,5-8,13,25,28H,3-4,9-12H2;5-10,13,25,28H,3-4,11-12H2,1-2H3/p+1/b29-23+;4*27-21+;2*26-20+
InChIKeyPVNJNLGXIUVCKK-SVABQDEASA-O
MW3297.62 g/mol
LogP33.30
Rot. Bonds47

About 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol

5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol (PubChem CID 172918593) has the molecular formula C161H169Br7N27O16+ and a molecular weight of 3297.62 g/mol. Its IUPAC name is 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol.

Molecular Properties

Compound Name5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
PubChem CID172918593
Molecular FormulaC161H169Br7N27O16+
Molecular Weight3297.62 g/mol
Exact Mass3288.75
IUPAC Name5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
SMILESCCC(CC)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCC(O)CN(C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCC(O)C[NH+](C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCCN1CCN(CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CCN(CC)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.Oc1[nH]c2ccc(Br)cc2c1C1=Nc2ccccc2/C1=N\OCCC1CCCC1.Oc1[nH]c2ccc(Br)cc2c1C1=Nc2ccccc2/C1=N\OCCN1CCCC1
InChIInChI=1S/C25H28BrN5O2.2C23H25BrN4O3.C23H22BrN3O2.C23H24BrN3O2.C22H21BrN4O2.C22H23BrN4O2/c1-2-9-30-10-12-31(13-11-30)14-15-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-16-17(26)7-8-21(19)28-25(22)32;2*1-3-15(29)13-28(2)10-11-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-12-14(24)8-9-19(17)26-23(20)30;24-15-9-10-19-17(13-15)20(23(28)26-19)22-21(16-7-3-4-8-18(16)25-22)27-29-12-11-14-5-1-2-6-14;1-3-14(4-2)11-12-29-27-21-16-7-5-6-8-18(16)25-22(21)20-17-13-15(24)9-10-19(17)26-23(20)28;23-14-7-8-18-16(13-14)19(22(28)25-18)21-20(15-5-1-2-6-17(15)24-21)26-29-12-11-27-9-3-4-10-27;1-3-27(4-2)11-12-29-26-20-15-7-5-6-8-17(15)24-21(20)19-16-13-14(23)9-10-18(16)25-22(19)28/h3-8,16,28,32H,2,9-15H2,1H3;2*4-9,12,15,26,29-30H,3,10-11,13H2,1-2H3;3-4,7-10,13-14,26,28H,1-2,5-6,11-12H2;5-10,13-14,26,28H,3-4,11-12H2,1-2H3;1-2,5-8,13,25,28H,3-4,9-12H2;5-10,13,25,28H,3-4,11-12H2,1-2H3/p+1/b29-23+;4*27-21+;2*26-20+
InChIKeyPVNJNLGXIUVCKK-SVABQDEASA-O
XLogP33.30
TPSA550.89 Ų
H-Bond Donors17
H-Bond Acceptors35
Rotatable Bonds47
Heavy Atoms211
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003297.62
LogP ≤ 533.30
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_imine_A(9)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-bromo-3-[(3E)-3-(2-piperazin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
CID 136387395
5-bromo-3-[(3E)-3-[2-(4-methylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 136387386
3-[(3E)-5-bromo-3-(2-piperazin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
CID 135779823
5-bromo-3-[(3E)-3-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 136387385
5-bromo-3-[(3E)-3-[2-(3-methylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 136950463
5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 136980950
5-bromo-3-[3-[2-(3-methylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 137019715
5-bromo-3-[3-(2-piperazin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
CID 137137667
5-bromo-3-[3-[2-(4-methylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 137166936
5-bromo-3-[3-[2-(3-methylpiperazin-4-ium-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 147606060
5-bromo-3-[3-(2-piperazine-1,4-diium-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
CID 147783468
5-bromo-3-[(3E)-3-(2-cyclohexylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-piperidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol;methane
CID 157186105

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol?
The IUPAC name of 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol (CID 172918593) is 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol.
What is the SMILES notation for 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol?
The canonical SMILES for 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol is CCC(CC)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCC(O)CN(C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCC(O)C[NH+](C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CCCN1CCN(CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CCN(CC)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.Oc1[nH]c2ccc(Br)cc2c1C1=Nc2ccccc2/C1=N\OCCC1CCCC1.Oc1[nH]c2ccc(Br)cc2c1C1=Nc2ccccc2/C1=N\OCCN1CCCC1.
What is the InChIKey of 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol?
The InChIKey is PVNJNLGXIUVCKK-SVABQDEASA-O. The full InChI is InChI=1S/C25H28BrN5O2.2C23H25BrN4O3.C23H22BrN3O2.C23H24BrN3O2.C22H21BrN4O2.C22H23BrN4O2/c1-2-9-30-10-12-31(13-11-30)14-15-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-16-17(26)7-8-21(19)28-25(22)32;2*1-3-15(29)13-28(2)10-11-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-12-14(24)8-9-19(17)26-23(20)30;24-15-9-10-19-17(13-15)20(23(28)26-19)22-21(16-7-3-4-8-18(16)25-22)27-29-12-11-14-5-1-2-6-14;1-3-14(4-2)11-12-29-27-21-16-7-5-6-8-18(16)25-22(21)20-17-13-15(24)9-10-19(17)26-23(20)28;23-14-7-8-18-16(13-14)19(22(28)25-18)21-20(15-5-1-2-6-17(15)24-21)26-29-12-11-27-9-3-4-10-27;1-3-27(4-2)11-12-29-26-20-15-7-5-6-8-17(15)24-21(20)19-16-13-14(23)9-10-18(16)25-22(19)28/h3-8,16,28,32H,2,9-15H2,1H3;2*4-9,12,15,26,29-30H,3,10-11,13H2,1-2H3;3-4,7-10,13-14,26,28H,1-2,5-6,11-12H2;5-10,13-14,26,28H,3-4,11-12H2,1-2H3;1-2,5-8,13,25,28H,3-4,9-12H2;5-10,13,25,28H,3-4,11-12H2,1-2H3/p+1/b29-23+;4*27-21+;2*26-20+.
What are the key properties of 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol?
5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol has a molecular weight of 3297.62 g/mol, XLogP of 33.30, 47 rotatable bonds, 17 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-3-[(3E)-3-(2-cyclopentylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-(diethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-ethylpentoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[2-hydroxybutyl(methyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-(2-hydroxybutyl)-methylazanium;5-bromo-3-[(3E)-3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-pyrrolidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol is sourced from PubChem (CID 172918593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).